Scientists To Test Whether Zika Can Kill Brain Cancer Cells

//delivery.vidible.tv/jsonp/pid=5668ae6ee4b0b5e26955d6a6/vid=56fd9634e4b03fc2a0662368/56000e19e4b0e4e194b84b31.js?m.embeded=cms_video_plugin_us.edit.huffpost.netfunction onPlayerReadyVidible(e){‘undefined’!=typeof HPTrack&&HPTrack.Vid.Vidible_track(e)}!function(e,i){if(e.vdb_Player){if(‘object’==typeof commercial_video){var a=”,o=’m.fwsitesection=’+commercial_video.site_and_category;if(a+=o,commercial_video[‘package’]){var c=’&m.fwkeyvalues=sponsorship%3D’+commercial_video[‘package’];a+=c}e.setAttribute(‘vdb_params’,a)}i(e.vdb_Player)}else{var t=arguments.callee;setTimeout(function(){t(e,i)},0)}}(document.getElementById(‘vidible_1’),onPlayerReadyVidible);

Scientists in Britain plan to harness the Zika virus to try to kill brain tumor cells in experiments that they say could lead to new ways to fight an aggressive type of cancer.

The research will focus on glioblastoma, the most common form of brain cancer, which has a five-year survival rate of barely 5 percent.

Zika causes severe disability in babies by attacking developing stem cells in the brain – but in adults, whose brains are fully formed, it often causes no more than mild flu-like symptoms.

In glioblastoma, the cancer cells are similar to those in the developing brain, suggesting that the virus could be used to target them while sparing normal adult brain tissue.

Experts say existing treatments have to be given at low doses to avoid damaging healthy tissue.

Researchers led by Harry Bulstrode at Cambridge University will use tumor cells in the lab and in mice to assess Zika’s potential.

The mosquito-borne virus has spread to more than 60 countries and territories in a global outbreak that was first identified in Brazil in 2015.

“Zika virus infection in babies [READ MORE HERE]

Source: Huffington Science

Aggregated News

Aggregated news from around the world, brought to you in a single source for convenience. These snippets of news include a link to the full article. Please peruse our other editorial and original content, as well.